Micah Etter, MD
banner
mettermd.bsky.social
Micah Etter, MD
@mettermd.bsky.social
very cool guy doing (mostly) inpatient/vascular #Neurology (rumored). passionate re:edu/medtraining/8bit/+! posts are mine. he/him
Pinned
🚨New thing release announcement! 🚨

StrokeBot.me is a free stroke code simulator for trainees! Practice workflows, interventions, disposition calls, and more!

This is just the initial release so bugs are expected and updates ongoing! Enjoy!

#Neurology #MedEd
StrokeBot.me - Acute Stroke Simulator
StrokeBot.me
Reposted by Micah Etter, MD
On September 24, ERAS will open to programs. Which means applicants have only 2 weeks left to decide which programs to signal.

And if you want to know how to allocate your signals in the most effective manner possible, I’ve got something for you:

thesheriffofsodium.com/2025/09/10/t...
The Applicant’s Guide to Strategic Preference Signaling
Whenever I discuss preference signaling on social media, one of the first replies is always “Wait – what’s that?” In the olden days, when an applicant was interested in a particular residency…
thesheriffofsodium.com
September 11, 2025 at 12:53 AM
Reposted by Micah Etter, MD
1/ Hello #medsky #neurosky #neurocritcare #FOAMEd have another brief case that I wanted to discuss with you and see if maybe you can learn something new or reinforce old knowledge!
September 3, 2025 at 8:00 PM
🚨NEW RELEASE🚨

🔍Daily neurology connections, anyone?

neuroconnections.me has launched with a free, fun micro-learning puzzle game every day! Still the initial release so let me know if you spot any bugs.🐛

Play and learn here: neuroconnections.me

#Neurology #MedEd
🧠 NeuroConnections
NeuroConnections.me
September 1, 2025 at 5:25 PM
🚨New thing release announcement! 🚨

StrokeBot.me is a free stroke code simulator for trainees! Practice workflows, interventions, disposition calls, and more!

This is just the initial release so bugs are expected and updates ongoing! Enjoy!

#Neurology #MedEd
StrokeBot.me - Acute Stroke Simulator
StrokeBot.me
August 26, 2025 at 4:44 PM
Reposted by Micah Etter, MD
Could a metal ion supplement that cost pennies per day protect from Alzheimer's disease?
erictopol.substack.com/p/lithium-an...
August 10, 2025 at 3:14 PM
Reposted by Micah Etter, MD
October 13, 2024 at 4:11 AM
Reposted by Micah Etter, MD
1/ Hello #medsky #neurosky #neurocritcare #FOAMEd have a brief case that I wanted discuss with you and see if maybe you can learn something new or reinforce old knowledge!
August 6, 2025 at 8:00 PM
Reposted by Micah Etter, MD
A 50-year-old woman presented to the emergency department with a 10-day history of a throbbing headache that had suddenly started after she had felt a “pop” in her back. The headache worsened with upright positioning and improved with lying flat. 1/4

#MedSky
July 24, 2025 at 7:06 PM
Reposted by Micah Etter, MD
Case series w/ cumulative total n=110 pts support use of rivastigmine as alternative antidote to physostigmine for anticholinergic delirium. Both oral & transdermal formulations of rivastigmine may expedite recovery #medsky #EMsky #pharmsky #emimcc #FOAMed

👉 link.springer.com/article/10.1...
Just the facts: rivastigmine for the management of anticholinergic toxicity - Canadian Journal of Emergency Medicine
Canadian Journal of Emergency Medicine -
link.springer.com
July 14, 2025 at 6:40 PM
Reposted by Micah Etter, MD
OpenEvidence is generally very good, but it's occasionally horrifically wrong

One place it falls down a lot is drug allergy (where it's often too conservative)

There are NO absolute contraindications to acetylcysteine for acetaminophen OD

Reported "allergy" = anaphylactoid rxns... (#1/3) #EMIMCC
July 6, 2025 at 2:26 PM
Reposted by Micah Etter, MD
You had MS even before you had symptoms. This study found increased absenteeism from work 6 years prior to diagnosis. jnnp.bmj.com/content/earl...
Prodromal phase of multiple sclerosis: evidence from sickness absence patterns before disease onset – a matched cohort study
Background We aimed to investigate the prodromal phase of multiple sclerosis (MS) by investigating annual sickness absence rates before MS onset. Methods A retrospective cohort study was conducted us...
jnnp.bmj.com
June 29, 2025 at 4:12 PM
Reposted by Micah Etter, MD
This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%!

Practice changing investigator-initiated RCT.

#ISTH2025
June 22, 2025 at 1:49 PM
Reposted by Micah Etter, MD
Peer review is being transformed by AI, whether we like it or not.

From my own experience, most researchers are using it wrong… and that’s because no one’s talking about it! Let me share some ideas on how to harness its potential to improve scientific publishing.
June 15, 2025 at 2:21 PM
Reposted by Micah Etter, MD
Herpes zoster vaccination eligibility reduced the probability of new dementia diagnoses, suggesting its potential preventive effect.

https://ja.ma/4lagSB6
June 22, 2025 at 1:00 PM
Reposted by Micah Etter, MD
What is the prevalence of elevated opening pressure in children with Alexander Disease?

In the current issue of #pedneuro journal, Joung et al. explore this question through analysis of opening pressure, MRI and examination in a cohort of 43 patients.

Read Here: buff.ly/UrvyLjh
June 22, 2025 at 4:04 PM
Reposted by Micah Etter, MD
INDEX trial: CT perfusion wasn't adequate for evaluating brain death.

huge problem: they're using clinical exam as the gold standard

I think most patients classified as brain dead by CT perfusion but alive by exam were dead... #1/2

#EMIMCC #CCR25
June 13, 2025 at 3:53 PM
"Plasma p-tau217 reliably identified clinic patients with Alzheimer's"🆒

"definitive results in 86% of patients" 🆒

"Integration of plasma Aβ42 minimally improved diagnostic performance"🐟

"Plasma p-tau217 levels were increased in patients with kidney dysfunction"🫘
Diagnostic performance of plasma p‐tau217 and Aβ42/40 biomarkers in the outpatient memory clinic
INTRODUCTION Plasma biomarkers of Alzheimer's disease (AD) represent accessible alternatives to positron emission tomography (PET) and cerebrospinal fluid (CSF)-based biomarkers in well-characterize.....
alz-journals.onlinelibrary.wiley.com
June 12, 2025 at 10:05 PM
🚨 Excited to announce my brand-new, all-in-one ICH calculator page! It brings together multiple intracerebral hemorrhage stroke calculators in one comprehensive spot for assessments + decisions. 🧠🩸

Explore, use, share, and REMIX!💿📼
Check it out here: tinyurl.com/ICHcalc
ICH Calculator One Stop Shop
tinyurl.com
May 29, 2025 at 9:47 PM
Reposted by Micah Etter, MD
#ThrowbackThursday to our episode on DAPT 🩸

Did you know that ticagrelor inhibits adenosine reuptake, which can cause bradycardia and dyspnea, sometimes resulting in patient self-discontinuation ‼️

www.coreimpodcast.com/2021/04/07/5...
May 29, 2025 at 11:07 AM
Reposted by Micah Etter, MD
For reasons, I was reading the 1902 memorial of early American neurologist J.T. Eskridge this morning - and Frank Norbury has some delightful thoughts on enthusiasm that I thought I'd share 1/5
May 26, 2025 at 3:40 PM
Reposted by Micah Etter, MD
In the TAK-861-2001 trial involving 112 participants with narcolepsy type 1, oveporexton significantly improved measures of wakefulness, sleepiness, and cataplexy over a period of 8 weeks. Full trial results and Research Summary: nej.md/3ZdlKNi

#MedSky #NeuroSky
May 26, 2025 at 1:33 PM
Reposted by Micah Etter, MD
A recent article seems to imply that we don't need to check an ECG before giving ondansetron.

This is largely correct, but I disagree with some of their points.

I wrote a letter to the editor that I posted in the blog, so you can access it easily here: emcrit.org/pulmcrit/twd... #EMIMCC
May 16, 2025 at 3:08 PM
Reposted by Micah Etter, MD
In a new editorial, Andrea L. Gropman, MD, and Alexis C. Komor, PhD, describe the foundations of an N-of-1 gene-editing study to treat an infant with a urea-cycle disorder. Read the editorial: nej.md/430hLWR

#ASGCT2025 @asgct.bsky.social #ScienceSky
Personalized Gene Editing to Treat an Inborn Error of Metabolism | NEJM
In this editorial, the authors describe the foundations of an N-of-1 gene-editing study to treat an infant with a urea-cycle disorder.
nej.md
May 15, 2025 at 5:08 PM
Reposted by Micah Etter, MD
1/ Hi 👋 #medtwitter #neurotwitter #neurocritcare #FOAMed #meded have an impressive image to show you in the form of another case, albeit, this one with a sad ending
May 14, 2025 at 8:00 PM